Q32 Bio INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
Q32 Bio Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for June 12, 2026, to elect directors, ratify auditor appointment, and vote on executive compensation.
NASDAQ
Q32 Bio Inc. announces its 2025 Annual Meeting to be held on June 13, 2025, featuring proposals including the election of directors, amendments to the certificate of incorporation, and ratification of the company's accounting firm.
NASDAQ
Q32 Bio Inc. is holding its 2025 Annual Meeting of Stockholders online on June 13, 2025, to vote on key proposals including director elections, an amendment to limit officer liability, and ratification of the company's accounting firm.